068270.KS
Celltrion, Inc.
KSC · Healthcare · Biotechnology · KR
KRW 187,100.00
+0.43%Margins
Gross margin
60.7%
EBITDA margin
39.4%
EBIT margin
31.6%
Net margin
32.2%
FCF margin
14.5%
8.8%
Return on equity
6.7%
Return on assets
7.1%
Return on invested capital
0.21x
Asset turnover
KRW 943.0B
Cash from operations
KRW 5.4K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026